The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2‐arachidonoylglycerol signalling through cannabinoid receptors
Open accessAbstract
The endocannabinoid 2‐arachidonoylglycerol (2‐AG) is a lipid mediator involved in various physiological processes. In response to neural activity, 2‐AG is synthesized post‐synaptically, then activates pre‐synaptic cannabinoid CB1 receptors (CB1Rs) in a retrograde manner, resulting in transient and long‐lasting reduction of neurotransmitter release. The signalling competence of 2‐AG is tightly regulated by the balanced action between ‘on demand’ biosynthesis and degradation. We review recent research on monoacylglycerol lipase (MAGL), ABHD6 and ABHD12, three serine hydrolases that together account for approx. 99% of brain 2‐AG hydrolase activity. MAGL is responsible for approx. 85% of 2‐AG hydrolysis and colocalizes with CB1R in axon terminals. It is therefore ideally positioned to terminate 2‐AG‐CB1R signalling regardless of the source of this endocannabinoid. Its acute pharmacological inhibition leads to 2‐AG accumulation and CB1R‐mediated behavioural responses. Chronic MAGL inactivation results in 2‐AG overload, desensitization of CB1R signalling and behavioural tolerance. ABHD6 accounts for approx. 4% of brain 2‐AG hydrolase activity but in neurones it rivals MAGL in efficacy. Neuronal ABHD6 resides post‐synaptically, often juxtaposed with CB1Rs, and its acute inhibition leads to activity‐dependent accumulation of 2‐AG. In cortical slices, selective ABHD6 blockade facilitates CB1R‐dependent long‐term synaptic depression. ABHD6 is therefore positioned to guard intracellular pools of 2‐AG at the site of generation. ABHD12 is highly expressed in microglia and accounts for approx. 9% of total brain 2‐AG hydrolysis. Mutations in ABHD12 gene are causally linked to a neurodegenerative disease called PHARC. Whether ABHD12 qualifies as a bona fide member to the endocannabinoid system remains to be established.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159 · cited 2×
“Indeed, CB1R is among the most abundantly expressed and widely distributed GPCR in the brain (Herkenham et al. 1991) (Fig.”
BackgroundThe molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957 · cited 2×
“…are produced ‘on demand’ and released from post-synaptic neurones, then activate pre-synaptic CB1Rs in a retrograde manner, resulting in transient and long-lasting reduction of neurotransmitter release at various central synapses (Alger 2002, Freund et al. 2003, Piomelli 2003, Kano et al. 2009).”
BackgroundInfluentialPertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Di Marzo, V., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,605
Role of Endogenous Cannabinoids in Synaptic Signaling
FREUND, T. F., KATONA, I., & PIOMELLI, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,574
Leptin-regulated endocannabinoids are involved in maintaining food intake
Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., et al. (2001) · Nature · doi:10.1038/35071088 · Cited by 1,559 · cited 1×
“In addition, MAGL-KO mice had decreased body weight, thus resembling the lean phenotype of CB1R-KO mice or animals treated with CB1R antagonists such as rimonabant (Di Marzo et al. 2001).”
BackgroundEndocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373 · cited 1×
“MAGL was the first hydrolase implicated in 2-AG degradation both in vitro and in vivo (Dinh et al. 2002, 2004, Saario et al. 2004, Labar et al. 2010b).”
BackgroundA Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
Blankman, J. L., Simon, G. M., & Cravatt, B. F. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.006 · Cited by 1,177 · cited 9×
“integral membrane protein (Blankman et al. 2007) and in the brain its mRNA is highly expressed in microglia.”
BackgroundMethodInfluentialBisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.-J., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305129 · Cited by 1,039
Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis
Nomura, D. K., Long, J. Z., Niessen, S., Hoover, H. S., Ng, S.-W., & Cravatt, B. F. (2010) · Cell · doi:10.1016/j.cell.2009.11.027 · Cited by 1,002 · cited 3×
“…(ABPP) of various cancer cells has identified MAGL overexpression as the key metabolic switch orchestrating cancer cell malignancy by redirecting lipids from storage sites towards biosynthesis of cancer promoting signalling lipids such as eicosanoids and lysophospholipids (Nomura et al. 2010).”
BackgroundInfluentialSelective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
Long, J. Z., Li, W., Booker, L., Burston, J. J., Kinsey, S. G., Schlosburg, J. E., Pavón, F. J., Serrano, A. M., Selley, D. E., Parsons, L. H., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.129 · Cited by 934
Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system
Schlosburg, J. E., Blankman, J. L., Long, J. Z., Nomura, D. K., Pan, B., Kinsey, S. G., Nguyen, P. T., Ramesh, D., Booker, L., Burston, J. J., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2616 · Cited by 641
Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids
E. Alger, B. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00080-1 · Cited by 598
Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses
Katona, I., Urbán, G. M., Wallace, M., Ledent, C., Jung, K.-M., Piomelli, D., Mackie, K., & Freund, T. F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0309-06.2006 · Cited by 511
CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS
Mackie, K. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141254 · Cited by 505
Gao, Y., Vasilyev, D. V., Goncalves, M. B., Howell, F. V., Hobbs, C., Reisenberg, M., Shen, R., Zhang, M.-Y., Strassle, B. W., Lu, P., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5693-09.2010 · Cited by 473
Tanimura, A., Yamazaki, M., Hashimotodani, Y., Uchigashima, M., Kawata, S., Abe, M., Kita, Y., Hashimoto, K., Shimizu, T., Watanabe, M., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.021 · Cited by 472
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors
Marrs, W. R., Blankman, J. L., Horne, E. A., Thomazeau, A., Lin, Y. H., Coy, J., Bodor, A. L., Muccioli, G. G., Hu, S. S.-J., Woodruff, G., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2601 · Cited by 441
cDNA Cloning, Tissue Distribution, and Identification of the Catalytic Triad of Monoglyceride Lipase
Karlsson, M., Contreras, J. A., Hellman, U., Tornqvist, H., & Holm, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.27218 · Cited by 422
Uchigashima, M., Narushima, M., Fukaya, M., Katona, I., Kano, M., & Watanabe, M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0448-07.2007 · Cited by 375
SUGIURA, T., KISHIMOTO, S., OKA, S., & GOKOH, M. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2006.03.003 · Cited by 352
The Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic Applications
Lambert, D. M., & Fowler, C. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058183t · Cited by 350
CB2receptors in the brain: role in central immune function
Cabral, G. A., Raborn, E. S., Griffin, L., Dennis, J., & Marciano‐Cabral, F. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707584 · Cited by 342
Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain
Kinsey, S. G., Long, J. Z., O’Neal, S. T., Abdullah, R. A., Poklis, J. L., Boger, D. L., Cravatt, B. F., & Lichtman, A. H. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155465 · Cited by 330 · cited 1×
“In contrast to the antinociceptive effects typically observed after acute MAGL inhibition (Kinsey et al. 2009, Long et al. 2009), animals with chronic MAGL blockade had normal pain responses in several pain models.”
ResultHashimotodani, Y., Ohno-Shosaku, T., Tsubokawa, H., Ogata, H., Emoto, K., Maejima, T., Araishi, K., Shin, H.-S., & Kano, M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.004 · Cited by 315
Fiskerstrand, T., H'mida-Ben Brahim, D., Johansson, S., M'zahem, A., Haukanes, B. I., Drouot, N., Zimmermann, J., Cole, A. J., Vedeler, C., Bredrup, C., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.08.002 · Cited by 240
Dinh, T. P., Kathuria, S., & Piomelli, D. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002071 · Cited by 229
Chanda, P. K., Gao, Y., Mark, L., Btesh, J., Strassle, B. W., Lu, P., Piesla, M. J., Zhang, M.-Y., Bingham, B., Uveges, A., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.068304 · Cited by 226
A Lipid Pathway for Ligand Binding Is Necessary for a Cannabinoid G Protein-coupled Receptor
Hurst, D. P., Grossfield, A., Lynch, D. L., Feller, S., Romo, T. D., Gawrisch, K., Pitman, M. C., & Reggio, P. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041590 · Cited by 200
Ahn, K., Johnson, D. S., & Cravatt, B. F. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903018857 · Cited by 194
Crystal Structure of the Human Monoacylglycerol Lipase, a Key Actor in Endocannabinoid Signaling
Labar, G., Bauvois, C., Borel, F., Ferrer, J., Wouters, J., & Lambert, D. M. (2010) · ChemBioChem · doi:10.1002/cbic.200900621 · Cited by 185
FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels.
Petrosino, S., & Marzo, V. D. (2010) · PubMed · Cited by 184
Jung, K.-M., Astarita, G., Zhu, C., Wallace, M., Mackie, K., & Piomelli, D. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.037796 · Cited by 170
Structural Basis for Human Monoglyceride Lipase Inhibition
Bertrand, T., Augé, F., Houtmann, J., Rak, A., Vallée, F., Mikol, V., Berne, P. F., Michot, N., Cheuret, D., Hoornaert, C., et al. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.11.060 · Cited by 168
Pan, B., Wang, W., Long, J. Z., Sun, D., Hillard, C. J., Cravatt, B. F., & Liu, Q.-S. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.158162 · Cited by 165
Saario, S. M., Savinainen, J. R., Laitinen, J. T., Järvinen, T., & Niemi, R. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.12.003 · Cited by 163
Self-citationSaario, S. M., Salo, O. M. H., Nevalainen, T., Poso, A., Laitinen, J. T., Järvinen, T., & Niemi, R. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.04.013 · Cited by 158
Self-citationA Review on the Monoacylglycerol Lipase: At the Interface Between Fat and Endocannabinoid Signalling
Labar, G., Wouters, J., & Lambert, D. M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791859414 · Cited by 130
Yoshida, T., Uchigashima, M., Yamasaki, M., Katona, I., Yamazaki, M., Sakimura, K., Kano, M., Yoshioka, M., & Watanabe, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012875108 · Cited by 126
Keimpema, E., Barabás, K., Morozov, Y. M., Tortoriello, G., Torii, M., Cameron, G. A., Yanagawa, Y., Watanabe, M., Mackie, K., & Harkany, T. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2126-10.2010 · Cited by 124
Marzo, V. D., Bisogno, T., & PETROCELLIS, L. D. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.05.014 · Cited by 123
Straiker, A. J., Hu, S. S., Long, J. Z., Arnold, A., Wager‐Miller, J., Cravatt, B. F., & Mackie, K. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.059030 · Cited by 108
Concerted Action of CB1 Cannabinoid Receptor and Deleted in Colorectal Cancer in Axon Guidance
Argaw, A., Duff, G., Zabouri, N., Cécyre, B., Chainé, N., Cherif, H., Tea, N., Lutz, B., Ptito, M., & Bouchard, J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4134-09.2011 · Cited by 102
Role of endocannabinoids and endovanilloids in Ca2+ signalling
PETROCELLIS, L. D., & Marzo, V. D. (2009) · Cell Calcium · doi:10.1016/j.ceca.2009.03.003 · Cited by 90
Ludányi, A., Hu, S. S., Yamazaki, M., Tanimura, A., Piomelli, D., Watanabe, M., Kano, M., Sakimura, K., Maglóczky, Z., Mackie, K., et al. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.10.062 · Cited by 83
Therapeutic Potential of Endocannabinoid‐Hydrolysing Enzyme Inhibitors
Saario, S. M., & Laitinen, J. T. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00130.x · Cited by 67
Self-citationSavinainen, J. R., Yoshino, M., Minkkilä, A., Nevalainen, T., & Laitinen, J. T. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.12.009 · Cited by 39
Self-citationLichtman, A. H., Blankman, J. L., & Cravatt, B. F. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.069427 · Cited by 38
Palomäki, V., Lehtonen, M., Savinainen, J. R., & Laitinen, J. T. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04403.x · Cited by 37
Self-citationMax, D., Hesse, M., Volkmer, I., & Staege, M. S. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01347.x · Cited by 36
Inhibitors of monoacylglycerol lipase as novel analgesics
Hohmann, A. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707153 · Cited by 24
Laitinen, J. T. (2004) · Current Neuropharmacology · doi:10.2174/1570159043476819 · Cited by 19
Self-citation
Cited by
The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12451 · Cited by 425
Sharma, P., Srivastava, P., Seth, A., Tripathi, P. N., Banerjee, A. G., & Shrivastava, S. K. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.006 · Cited by 331
Why do cannabinoid receptors have more than one endogenous ligand?
Di Marzo, V., & De Petrocellis, L. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0382 · Cited by 290
Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation
Galve-Roperh, I., Chiurchiù, V., Díaz-Alonso, J., Bari, M., Guzmán, M., & Maccarrone, M. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.05.004 · Cited by 283
Cannabis use during adolescent development: Susceptibility to psychiatric illness
Chadwick, B., Miller, M. L., & Hurd, Y. L. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00129 · Cited by 210
Metadata
- Authors
- Savinainen, J. R., Saario, S. M., & Laitinen, J. T.
- Venue
- Acta Physiologica
- Publisher
- Wiley
- Published
- 2011-04-22
- Volume
- 204
- Issue
- 2
- Pages
- 267-276
- ISSN
- 1748-1708 (ISSN-L)
- 1748-1716
- OpenAlex
- W1482026204
- Cited by
- 299
- References
- 52
- FWCI
- 13.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.